What Will Happen to IntelliPharmaCeutics International Inc. Next? The Stock Just Has Increased A Lot

 What Will Happen to IntelliPharmaCeutics International Inc. Next? The Stock Just Has Increased A Lot

The stock of IntelliPharmaCeutics International Inc. (TSE:I) is a huge mover today! About 29,450 shares traded hands. IntelliPharmaCeutics International Inc. (TSE:I) has risen 29.74% since March 14, 2016 and is uptrending. It has outperformed by 24.20% the S&P500.
The move comes after 5 months positive chart setup for the $103.33M company. It was reported on Oct, 19 by Barchart.com. We have $8.08 PT which if reached, will make TSE:I worth $122.96M more.

IntelliPharmaCeutics International Inc is a Canada pharmaceutical firm specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The company has a market cap of $103.33 million. The Company’s Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. It currently has negative earnings. It has developed several drug delivery systems and a pipeline of products and product candidates in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.

I.TO Company Profile

Intellipharmaceutics International Inc., incorporated on October 22, 2009, is a pharmaceutical firm specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The Company’s Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, the Company has developed several drug delivery systems and a pipeline of products and product candidates at various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. The Hypermatrix family of technologies includes IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliPellets, IntelliShuttle, Point of Divergence Drug Delivery System (nPODDDS) and Paradoxical OverDose Resistance Activating System (PODRAS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment